Corient Private Wealth
NUVB icon

Corient Private Wealth’s Nuvation Bio NUVB Stock Holding History

Corient Private Wealth’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Sell
344,163
-164,043
-32% -$914K ﹤0.01% 1423
2025
Q4 		$4.55M Buy
+508,206
New +$3.15M ﹤0.01% 1094
2023
Q3 		– Sell
-16,420
Closed -$29.6K – 2207
2023
Q2 		$29.6K Buy
+16,420
New +$27.9K ﹤0.01% 2038

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Corient Private Wealth's NUVB Position: Q1 2026 in Review

Corient Private Wealth reduced its Nuvation Bio (NUVB) stake by 32% in Q1 2026, selling an estimated $914K and leaving 344,163 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

Corient Private Wealth first reported a position in NUVB in Q2 2023 and has held it in 3 quarters since. The position peaked at $4.55M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Corient Private Wealth held 344,163 shares of Nuvation Bio worth $1.48M as of Q1 2026.
  • Corient Private Wealth sold 164,043 Nuvation Bio shares in Q1 2026, an estimated $914K.
  • Nuvation Bio made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1423 holding.
  • Corient Private Wealth first reported a position in Nuvation Bio in Q2 2023 and has held it in 3 quarters since.
  • Corient Private Wealth's Nuvation Bio position peaked at $4.55M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.